István Wittmann
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Papers in
- Nephrology 34
- Chronic Kidney Disease and Diabetes 21
- Renal Diseases and Glomerulopathies 14
-
- Diabetes Treatment and Management 32
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Diet, Metabolism, and Disease 11
- Co-authors
- G MolnárBoglárka LaczyMárton MohásLajos MarkóBalázs SümegiJudit NagyJudit CsehIstván András Szijártó
- Journals
- Kidney & Blood Pressure Research (7 papers)Diabetes Research and Clinical Practice (5 papers)Nephrology Dialysis Transplantation (5 papers)Hormone and Metabolic Research (3 papers)Redox Report (3 papers)
- Partner nations
- HungaryUnited StatesGermany
In The Last Decade
István Wittmann
166 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Geriatrics and Gerontology 315
- Nephrology 333
- Clinical Biochemistry 312
- Endocrinology, Diabetes and Metabolism 716
- Physiology 584
Countries citing papers authored by István Wittmann
This map shows the geographic impact of István Wittmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Wittmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Wittmann more than expected).
Fields of papers citing papers by István Wittmann
This network shows the impact of papers produced by István Wittmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Wittmann. The network helps show where István Wittmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside István Wittmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 1 | |
| 14 | 2020 | 14 | |
| 15 | Apolipoprotein A5 gene APOA5*2 haplotype variant confers risk for the development of metabolic syndrome | 2008 | 0 |
| 16 | 2006 | 6 | |
| 17 | [Search for mitochondrial DNA T4291C mutation in Hungarian patients with metabolic syndrome]. | 2006 | 3 |
| 18 | 2006 | 65 | |
| 19 | 2005 | 43 | |
| 20 | 2005 | 44 |
About István Wittmann
István Wittmann is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Physiology and Cardiology and Cardiovascular Medicine, having authored 189 papers that have together received 2.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (32 papers), Metabolism, Diabetes, and Cancer (24 papers), Chronic Kidney Disease and Diabetes (21 papers), Diet and metabolism studies (15 papers), Advanced Glycation End Products research (15 papers), Renal Diseases and Glomerulopathies (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Diet, Metabolism, and Disease (11 papers). The work is most often cited by research in Geriatrics and Gerontology (315 citations), Nephrology (333 citations), Clinical Biochemistry (312 citations), Endocrinology, Diabetes and Metabolism (716 citations) and Physiology (584 citations). István Wittmann has collaborated with scholars based in Hungary, United States and Germany. Frequent co-authors include G Molnár, Boglárka Laczy, Márton Mohás, Lajos Markó, Balázs Sümegi, Judit Nagy, Judit Cseh, István András Szijártó, Pál Brasnyó and Esztella Mikolás. Their work appears in journals such as Kidney & Blood Pressure Research, Diabetes Research and Clinical Practice, Nephrology Dialysis Transplantation, Hormone and Metabolic Research and Redox Report.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.